logo

For the Inventor, By the Inventor

Urawa, Japan

Takeshi Nagasawa

This inventor holds 38 USPTO granted patents, primarily in Biochemical Assays. Top assignees: Nitto Boseki Co., Ltd., Iatron Laboratories Inc., Sagami Chemical Research Center. Active years: 1976-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Nagasawa. Retrieved from https://idiyas.com/inventor/takeshi-nagasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 184(Granted Patents)


Location History:

  • Koriyama, JA (1976)
  • Korujama, JA (1976)
  • Koriyama, JP (1980 - 1986)
  • Urawa, JP (1986 - 2001)

Company Filing History:

goldMedal38 out of 266 
 
Nitto Boseki Co., Ltd.
 patents
silverMedal3 out of 33 
 
Iatron Laboratories Inc.
 patents
bronzeMedal1 out of 191 
 
Sagami Chemical Research Center
 patents
where one patent can have more than one assignee

Years Active: 1976-2001

Loading Chart...
Areas of Expertise:
Biochemical Assays
Enzyme Activity
Peptide Derivatives
Cholinesterase Activity
Kallikrein Measurement
Acid Phosphatase
Thrombin Measurement
Glucosamine Derivatives
Tripeptide Derivatives
Synthetic Peptidic Substrates
Quantitative Assays
Monoclonal Antibodies
38 patents (USPTO):Explore Patents
1. 6268166 - Method of quantitative assay for 1,5-anhydroglucitol (2001-07-31),
2. 5869276 - Method for determination of direct bilirubin and reagent therefor (1999-02-09),
3. 5719030 - Monoclonal antibody to prostate-derived acid phosphatase and method for (1998-02-17),
4. 5508385 - Tripeptide derivatives containing pyroglutamic acid residue (1996-04-16),
5. 5486458 - Method of quantitative assay for 1,5-anhydroglucitol (1996-01-23),
6. 5468621 - Method of quantitative assay for 1,5-anhydroglucitol (1995-11-21),
7. 5416238 - L-argininal acetal derivatives and a process for production thereof (1995-05-16),
8. 5399488 - Method for assaying enzyme activity using N-acetyl-.beta.-D-glucosamine (1995-03-21),
9. 5227291 - Method for determination of acid phosphatase activity using 4-acyl-2, (1993-07-13),
10. 5153176 - Tripeptide derivatives and protease inhibitor composition comprising the (1992-10-06),
11. 5151372 - Method for determination of hydroxyacetophenone derivatives (1992-09-29),
12. 5126329 - Glucosamine derivatives and compositions reagents and containing the same (1992-06-30),
13. 5116941 - Peptide substrates for determination of enzyme activity (1992-05-26),
14. 5115099 - Substrates for determination of enzyme activity and intermediates for (1992-05-19),
15. 5081274 - 4-acyl-2,6-dihalophenyl-phosphoric acid derivatives useful in the (1992-01-14),

Title: The Innovative Journey of Takeshi Nagasawa

Introduction: Takeshi Nagasawa, a pioneering inventor hailing from Urawa, Japan, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Takeshi Nagasawa holds several recent patents in the field of robotics and artificial intelligence, showcasing his continuous dedication to innovation and advancement in these areas.

Career Highlights: With a career spanning over two decades, Takeshi Nagasawa has established himself as a leading figure in the tech industry. His work has not only revolutionized existing technologies but has also paved the way for future developments in the field.

Collaborations: Throughout his career, Takeshi Nagasawa has collaborated with top research institutions and leading tech companies to further his inventions and bring them to the market. His collaborative efforts have resulted in cutting-edge products that have had a lasting impact on the industry.

Conclusion: Takeshi Nagasawa's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…